What Is Micropulse Cyclophotocoagulation?

How Does the "Pulsing" Mechanism Prevent Eye Inflammation?

The "Micropulse" technology uses a 5 percent "duty cycle" meaning the laser is only firing for a tiny fraction of a second. This allows the surrounding tissue to "rest and cool" between each pulse. In traditional lasers the heat can cause severe inflammation and "uveitis" following the procedure. Clinical data indicates that MP-CPC results in 60 percent less post-operative pain and inflammation than older "continuous wave" lasers. This mechanism is mandatory for preserving the "anatomy" of the eye, allowing the procedure to be repeated multiple times if needed.

What are the Primary Success Data Trends for Glaucoma Pressure?

Clinical studies show that MP-CPC is highly successful at lowering eye pressure to a safe level. Statistics indicate that intraocular pressure (IOP) drops by an average of 30 to 40 percent after a single treatment. Data suggest that nearly 75 percent of patients can reduce the number of daily eye drops they need after the procedure. This has made MP-CPC a primary treatment for "Moderate-to-Advanced" glaucoma where drops alone are no longer enough to stop the "silent thief of sight."

Why Is MP-CPC the Preferred Choice for "Good Vision" Glaucoma?

In the past cyclophotocoagulation was only used for "blind" or painful eyes because the risk of vision loss was too high. Because Micropulse technology is "non-destructive" it is now safely used on eyes with 20/20 vision. Data indicate that the risk of a permanent "vision drop" (phthisis) with MP-CPC is less than 1 percent compared to over 10 percent with older versions. This safety data has shifted the standard of care, allowing clinicians to offer the laser earlier in the disease process to protect the patient's remaining sight.

What are the Specific Signs of a Successful "Laser Sweep"?

During the procedure the surgeon "sweeps" the laser probe across the top and bottom halves of the eye. The success of the procedure depends on the "total energy" delivered which is measured in Joules. Clinicians use a standardized "slow-sweep" technique to ensure even coverage of the ciliary body. Data shows that patients who receive at least 100 Jou of energy per hemisphere have a 20 percent higher success rate in maintaining low pressure for over one year.

How Do Clinicians Manage "Pressure Spikes" After the Laser?

A common side effect of any glaucoma laser is a temporary "spike" in eye pressure immediately after the procedure. Statistics show that nearly 15 percent of patients will have a brief rise in pressure due to the "shock" to the eye's drainage system. Surgeons manage this by giving the patient a "cocktail" of extra pressure-lowering pills and drops for the first 24 hours. Monitoring the pressure one hour after the laser is a mandatory safety protocol to ensure that the patient's optic nerve is never at risk during the recovery phase.